Search research articles
Contact Us
Filters
Showing results (321-330 of 346) with videos related to
Page
of 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group
A Thyss, S Suciu, Y Bertrand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
M Moehler, A Maderer, P C Thuss-Patience, et al.
British Journal of Haematology
|
August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study
P Bordigoni, H Esperou, G Souillet, et al.
British Journal of Cancer
|
October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)
Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 24, 2007
[Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies]
G Adler, T Seufferlein, S C Bischoff, et al.
Zeitschrift Fur Gastroenterologie
|
July 4, 2007
[S3-Guidelines "Exocrine pancreatic cancer" 2007]
G Adler, T Seufferlein, S C Bischoff, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 346) with videos related to
Sort By:
Page
of 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group
A Thyss, S Suciu, Y Bertrand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
M Moehler, A Maderer, P C Thuss-Patience, et al.
British Journal of Haematology
|
August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study
P Bordigoni, H Esperou, G Souillet, et al.
British Journal of Cancer
|
October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)
Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 24, 2007
[Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies]
G Adler, T Seufferlein, S C Bischoff, et al.
Zeitschrift Fur Gastroenterologie
|
July 4, 2007
[S3-Guidelines "Exocrine pancreatic cancer" 2007]
G Adler, T Seufferlein, S C Bischoff, et al.
Page
of 35